Clinical Trial Update: Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of durvalumab in leptomeningeal metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis
• Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Hui Bu | Conditions: Leptomeningeal Metastasis, Durvalumab | Phase 4 | Status: UNKNOWN